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Abstract
Introduction: Venous thromboembolism occurs ten times more often among pregnant women compared to 
non-pregnant ones. Pulmonary embolism remains the leading cause of death in pregnancy and puerperium.
The aim of the study was to investigate knowledge of pregnant or puerperal women about venous thrombo-
embolism.
Material and methods: The study was conducted from October 2017 to January 2018 in a group of 204 
women. The diagnostic survey method was applied with the use of a self-designed questionnaire. The survey 
was conducted using Google Form.
Results: Knowledge of venous thromboembolism was confirmed by less than 40.0% [CI 33.7, 47.0] of re-
spondents. Less than a quarter of them received the information about the risk of pregnancy-related VTE from 
medical personnel, about 30% — from the Internet. Over 20% [CI 15.2, 26.1] admitted that they did not 
know any symptoms of this disease.
Conclusions: The survey showed marked deficiencies in knowledge concerning symptoms, risk factors and 
prevention of VTE among pregnant women. Therefore a special emphasis should be placed on education provided 
by medical staff in this group of patients.
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Introduction
Pulmonary embolism is the leading cause of death 
among pregnant and puerperal women [1–5]. The inci-
dence of venous thromboembolic disease (VTE) among 
pregnant women is much higher than in a comparable 
non-pregnant age group [1–7].
The risk of VTE covers the whole period of pregnan-
cy; however, 40% of episodes occur in the first trimes-
ter, especially in the case of in vitro fertilization [6–10]. 
The risk of pulmonary embolism is also increased in 
the postpartum period, especially after caesarean 
section [2, 5, 11]. Despite the decrease in the number 
of thromboembolic complications resulting from the 
fast mobilization of women after childbirth and their 
early return home, pulmonary embolism remains the 
main cause of death of women during pregnancy and 
confinement in developing countries [1–6].
The most common symptoms suggestive of deep 
vein thrombosis include [5, 12–14]: pain, swelling of 
the lower leg with a difference in their circumferences 
above 2 cm, tenderness or pain in the limb, excessive 
limb warm-up, redness of the skin, widespread superficial 
veins, subfebrile state, and — less frequently — fever.
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Pulmonary embolism should be suspected if there 
is: dyspnoea, tachypnoea, pleural chest pain (worsen-
ing during inspiration), coronary pain, haemoptysis or 
fainting [5, 12–14].
Nevertheless, the disease may be asymptomatic or 
oligosymptomatic in up to 70% of patients. Moreover, 
in the case of pregnant women, the diagnosis of VTE is 
more difficult, because symptoms such as calf oedema 
and dyspnoea may also occur in the course of normal 
pregnancy [5, 12–14].
Each woman planning or being at an early stage 
of pregnancy should be assessed for VTE risk factors 
[2, 11] (Table 1) and then qualified for one of three risk 
groups for the disease: high, moderate or low (Table 2). 
Appropriate preventive measures should be used 
depending on the predicted risk of VTE [2, 11].
Prophylaxis of venous thromboembolism may be 
primary – before the occurrence of a VTE episode, or 
secondary – after diagnosis of VTE in the past. Apart 
from early start-up, the other modes of prevention, 
such as mechanical methods (graded pressure stockings, 
intermittent pneumatic pressure) [2, 5, 11, 15–16] as 
well as pharmacological ones (low molecular weight 
heparins — LMWH) are recommended.
The choice of the method to prevent thromboem-
bolic complications should be considered individually 
depending on the risk of thrombotic complications 
(table 2).
Prophylactic treatment should be considered both 
after giving birth in a natural way and after caesarean 
delivery. It is particularly important in women with 
thrombophilia and in patients who have already ex-
perienced an episode of VTE. If there are at least 
two risk factors, such as obesity or age over 35 years, 
Table 1. Risk factors for venous thromboembolism
Pre-existing risk factors
Recurrent episodes of VTE in the past
VTE with no obvious cause or history of use estrogen
VTE related to the catchy cause
Family history of VTE
Known thrombophilia
Comorbidities, e.g. heart or lung diseases, systemic lupus, 
cancer, inflammatory diseases, nephritic syndrome, sickle 
cell disease, use of intravenous drug
Age > 35 years
Obesity BMI > 30 kg/m²





Dehydration/excessive vomiting/ovarian hyperstimulation 
syndrome




Prolonged delivery > 24 hours




Surgery during pregnancy or < 6th week of confinement
Table 2. Risk groups depending on risk factors
Risk groups Definition Preventive actions
High risk Recurrent episodes of VTE in an interview  
(> 1 episode) 
= VTE with no obvious cause or related to use  
estrogen
Single episode + thrombophilia or family history
Recommended LMWH prevention during pregnancy 
and in childbirth 




≥ 3 risk factors other than those listed under the high 
risk category
≥ 2 risk factors other than those listed in the high risk 
category if the patient is hospitalized
LMHH prophylaxis should be considered 
Prophylaxis should be given after delivery for at least 
7 days 
Graded compression stockings should be considered 
during pregnancy and confinement
low risk < 3 risk factors Early commissioning is recommended 
Avoiding dehydration is recommended
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anticoagulant prophylaxis and/or graded compression 
stockings should be considered for at least the duration 
of hospital stay [3, 5, 11]. If multiple risk factors coexist, 
prophylaxis should also be considered after the patient 
has been discharged [3, 5, 11].
Preventive measures in women after natural child-
birth and after caesarean section, which are not bur-
dened with additional risk factors, should be limited to 
early start-up and proper hydration [5, 11].
It is also important to avoid long-term travel in 
a seated position. The preventive methods of VTE dur-
ing the journey should include frequent activities such 
as stretching the lower leg muscles, and whole body 
stretching exercises, wearing loose clothing, avoiding 
dehydration. If the journey lasts for more than 8 hours, 
it is recommended to use knee-high socks with gradual 
pressure, providing 15–30 mm Hg compression at the 
level of the ankle [5, 11].
The knowledge of pregnant women concerning risk 
and symptoms of VTE is very important, as it may help 
them to seek medical help quickly, and encourage them 
to take appropriate preventive measures.
Thus the goal of the present study was to investigate 
knowledge of pregnant or puerperal women about 
venous thromboembolism.
Material and methods
The method chosen for the study was the one of 
the diagnostic survey, the technique of polling with the 
use of a self-designed questionnaire, consisting of 20 
closed questions, of which 13 concerned the topic of 
deep vein thrombosis (Fig. 1). The remaining six ques-
tions referred to the age, place of residence, education, 
week of pregnancy, the number of pregnancies/lay-ups, 
constancy of gynaecologist’s care. Questions 1, 2, 8, 10, 
11, 12 and 13 use the conjunctive cafeteria method. In 
questions 4, 5, 6, 7, 8, 14 it was possible to choose only 
one answer (disjunctive cafeteria). In the third question 
of the questionnaire, a five-point Likert scale was used.
The study was conducted within four months (from 
October 2017 to January 2018).
A mini pilot study was carried out among ten wom-
en during pregnancy and puerperium. The women 
surveyed did not make any comments, the questions 
were understandable. 
The survey was conducted using Google Form, by 
providing a questionnaire on the Facebook social net-
work website. The assumed average time of answering 
the questions was about 5 minutes. The selection of 
a random group was used in the work.




The most numerous age groups were respondents 
in the range of 26–35 years (63% [CI 56.4, 69.6]) and 
18–25 years (31% [CI 24.9, 37.5]).
The highest percentage of respondents were wom-
en with higher education (71% [CI 64.5, 76.9]) and 
secondary education (26% [CI 20.4, 32.4]). The lowest 
(3% [CI 1.44, 6.3]) — women with primary education.
The majority of women were in their first pregnancy 
or their first parturition (56% [CI 49.0, 62.5]). For 34% 
[CI 27.7, 40.6] of the respondents it was the second 
pregnancy or puerperium.
Almost all of the examined women (98% [CI 95.1, 
99.2]) were under the constant care of a gynaecologist 
during pregnancy.
Assessment of the knowledge of venous 
thromboembolism among the studied women
The surveyed women were asked about the knowl-
edge of diseases that may occur and are characteristic 
of pregnancy. Knowledge of venous thromboembolism 
was confirmed by less than 40.0% [CI 33.7, 47.0] of 
respondents. 
Women’s knowledge about diseases that may occur 
during pregnancy did not come from medical personnel. 
When asked about “what possible diseases in pregnancy 
were you informed about by a gynaecologist/midwife/
nurse?”, the women listed: maternal gestational dia-
betes TORCH and Rh incompatibility. Only 23.0% [CI 
17.8, 29.3] of the respondents received information 
about VTE. Worrying is the fact that a quarter of 
women declared that they did not receive information 
from medical staff about any of the diseases mentioned 
above.
Women were also asked a question about the most 
common cause of pregnancy-related deaths. Almost 
39% [CI 32.8, 46.1] of women did not have knowledge 
on this subject, only about 36% [CI 29.5, 42.6] of re-
spondents correctly pointed to pulmonary embolism.
Unfortunately, only less than a quarter of women 
surveyed received the information about the risk of 
pregnant VTE from medical personnel.
Half of the women surveyed (50.0% [CI 43.2, 
56.8]) declared that they were familiar with the spe-
cific term “venous thromboembolism”. About 30% 
of respondents learned about VTE from the Internet. 
Other sources of information were studies (16.7% [CI 
12.2, 22.4]), doctor (13.7% [CI 9.7, 19.1]) and friends/ 
/family (12.7% [CI 8.8, 18.0]). Only about 11% [CI 7.2, 
15.8] of the respondents obtained knowledge about 
VTE from a nurse or midwife (Fig. 1).
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Assessment of knowledge of risk factors  
for venous thromboembolism among  
the studied women
Over 60% [CI 53.0, 66.3] of respondents correctly 
answered that pregnancy and puerperium increase 
the risk of VTE. However, 36% [CI 29.5, 42.6] of 
women were unable to indicate the right answer to 
this question.
Almost 17% [CI 12.6, 22.9] of respondents ad-
mitted that they did not know any risk factor for VTE 
(Fig. 2).
Respondents asked about obstetric risk factors for 
venous thromboembolic disease most frequently indi-
cated immobilisation (47.5% [CI 40.8, 54.4]. Slightly 
fewer respondents indicated surgery (24.5% [CI 19.1, 
30.8]) or caesarean section (27% [CI 21.3, 33.4]). Al-
Figure 1. Sources of the respondents’ knowledge about venous thromboembolism (%). *Percentages do not add up because the 



















Figure 2. Knowledge about risk factors for venous thromboembolism among the studied women (%). *Percentages do not add 
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most 1/3 of surveyed women didn’t know any obstetric 
VTE risk factors (32.4% [CI 26.3, 39.0]) (Fig. 3).
Assessment of knowledge about  
the symptoms of venous thromboembolism 
among the studied women
Due to the change in the colour of the skin of one 
leg, medical assistance would be sought by ¾ women 
(rather yes — 21.6% [CI 16.5, 27.7], definitely yes — 
53.9% [CI 47.1, 60.6]). A swelling of one leg would 
induce half of the women surveyed to report to the 
doctor and calf pain only about 13% [CI 9.3, 18.6]. 
Dyspnoea and cough for just over half of the respond-
ents would be disturbing enough to go to the doctor 
immediately.
More than 70% [CI 63.5, 76.0] of respondents 
correctly indicated that pain, swelling, redness of one 
limb are symptoms that may signal deep vein thrombo-
sis. Less than 50% [CI 43.2, 56.8] of the respondents 
indicated tenderness or painfulness of the limb. Only 
about one third of the surveyed women pointed to limb 
warming (33.3% [CI 27.2, 40.1]) and enlargement of 
superficial veins of the limb (30.4% [CI 24.5, 37.0]). 
Almost half of the respondents incorrectly identified 
pain and swelling of both legs with deep vein throm-
bosis. Just over 20% [CI 15.2, 26.1] of respondents 
admitted that they did not know any symptoms of this 
disease (Fig. 4).
Symptoms indicative of pulmonary embolism include 
dyspnoea, tachypnoea, chest pain increasing during in-
spiration, cough, haemoptysis and collapse. Over 70% 
of respondents correctly indicated dyspnoea (72.5% 
[CI 66.1, 78.2]) and pleural pain, increasing during in-
spiration (73.5% [CI 67.1, 79.1]). Worrying is that to 
a much lesser extent women indicated other equally 
important symptoms of pulmonary embolism, such as 
tachypnoea (41.7% [CI 35.1, 48.5]) or haemoptysis 
(12.3% [CI 8.4, 17.5]) (Fig. 5).
Assessment of knowledge on the principles 
of prevention of venous thromboembolism 
among the studied women
Most women (95% [CI 91.2, 97.3]) correctly identi-
fied the need for proper hydration. Women often chose 
answers such as tobacco abstinence (94.5% [CI 90.6, 
97.0]) or maintaining normal body mass (90.7% [CI 
85.9, 94.0]). It is astonishing to note that definitely fewer 
respondents indicated relaxing of calf muscles (64.2% 
[CI 57.4, 70.5]), wearing graduated bracing knee socks 
(50% [CI 43.2, 56.8]) or heparin injection (56% [CI 49.0, 
62.5]). Unfortunately, 11% [CI 7.2, 15.8] of pregnant or 
puerperium women think they should consume alcohol 
in moderate amounts to prevent VTE.
Discussion
In the course of our study, women`s knowledge 
regarding venous thromboembolism during pregnan-
cy and confinement was analysed. Unfortunately only 
half of the women surveyed reported that they were 
familiar with the term “venous thromboembolism”. 
The importance of our findings is reflected in potential 
consequences of those knowledge deficits, because 
pulmonary embolism is still the leading cause of death 
among pregnant women and puerperium [1–5] and the 
incidence of venous thromboembolic disease among 
pregnant women is much higher than in a comparable 
non-pregnant age group [1–7].
Figure 3. Knowledge of respondents about pregnancy and puerperal related risk of VTE (%). * Percentages do not add up because 








Multiple pregnancy or assisted reproduction (eg in vitro)
Cesarean section
Prolonged childbirth (> 24 hours)
Perinatal haemorrhage
Immobilization (eg a long travel)
Surgery during pregnancy or < 6 weeks 
of postpartum time
I do not know
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Although 63% of respondents correctly answered 
that pregnancy and puerperium increase the risk of 
VTE, less than half of women could point to specific 
pregnancy and puerperium situations that increase the 
risk of disease.
The results of our study were similar to those ob-
tained in the study by Mellon et al. who investigated 
awareness of pregnancy-associated health risks among 
pregnant women and male partners and showed signif-
icant knowledge deficiencies concerning common and 
serious health hazards associated with pregnancy [17].
Because of great deficiencies in knowledge of symp-
toms, risk factors and methods of prevention of venous 
thromboembolism, a special emphasis in education 
should be placed on these issues.
Public health campaigns could help increase 
awareness about the wide range of pregnancy-as-
sociated health conditions among pregnant woman 
and puerperium. It is worrying that only about 11% 
of the respondents obtained knowledge about VTE 
from a nurse or midwife, who are trained to educate 
patients.
Figure 4. Symptoms of deep vein thrombosis in the respondents’ opinion (%). * Percentages do not add up because  
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Figure 5. Symptoms of pulmonary embolism in the respondents’ opinion (%). *Percentages do not add up because  
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Given the fact, that currently the Internet is the basic 
source of knowledge, especially for young people, it is 
worth paying attention to the reliability of information 
contained therein. At the same time, the Internet, due 
to its availability, should be used by professionals to 
improve knowledge not only about VTE but also other 
diseases of great epidemiological importance.
Conclusions
The incidence of venous thromboembolic dis-
ease among pregnant women is much higher than in 
a comparable non-pregnant age group and pulmonary 
embolism is the leading cause of death among pregnant 
women and puerperium.
Unfortunately, women’s knowledge of venous 
thromboembolism was insufficient and currently the 
most common source of information not only for 
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